1
|
Gomes F, Ribeiro AC, Sanches GS, Borges HS, Takahashi LAU, Daniel-Ribeiro CT, Tedesco AC, Nascimento JWL, Carvalho LJM. A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver. Antimicrob Agents Chemother 2024; 68:e0091523. [PMID: 38517190 PMCID: PMC11064505 DOI: 10.1128/aac.00915-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Accepted: 02/25/2024] [Indexed: 03/23/2024] Open
Abstract
Primaquine is the mainstream antimalarial drug to prevent Plasmodium vivax relapses. However, this drug can induce hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency. Nanostructure formulations of primaquine loaded with D-galactose were used as a strategy to target the drug to the liver and decrease the hemolytic risks. Nanoemulsion (NE-Pq) and nanochitosan (NQ-Pq) formulations of primaquine diphosphate containing D-galactose were prepared and characterized by their physicochemistry properties. Pharmacokinetic and biodistribution studies were conducted using Swiss Webster mice. A single dose of 10 mg/kg of each nanoformulation or free primaquine solution was administered by gavage to the animals, which were killed at 0.5, 1, 2, 4, 8, and 24 hours. Blood samples and tissues were collected, processed, and analyzed by high-performance liquid chromatography. The nanoformulation showed sizes around 200 nm (NE-Pq) and 400 nm (NQ-Pq) and physicochemical stability for over 30 days. Free primaquine solution achieved higher primaquine Cmax in the liver than NE-Pq or NQ-Pq at 0.5 hours. However, the half-life and mean residence time (MRT) of primaquine in the liver were three times higher with the NQ-Pq formulation than with free primaquine, and the volume distribution was four times higher. Conversely, primaquine's half-life, MRT, and volume distribution in the plasma were lower for NQ-Pq than for free primaquine. NE-Pq, on the other hand, accumulated more in the lungs but not in the liver. Galactose-coated primaquine nanochitosan formulation showed increased drug targeting to the liver compared to free primaquine and may represent a promising strategy for a more efficient and safer radical cure for vivax malaria.
Collapse
Affiliation(s)
- F. Gomes
- Laboratory of Malaria Research, Oswaldo Cruz Institute (IOC/Fiocruz), Reference Center for Malaria Research, Diagnosis and Training, Rio de Janeiro, Brazil
| | - A. C. Ribeiro
- Laboratory of Malaria Research, Oswaldo Cruz Institute (IOC/Fiocruz), Reference Center for Malaria Research, Diagnosis and Training, Rio de Janeiro, Brazil
- Department of Pharmacology (LaFaCE) - ICB, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Minas Gerais, Brazil
| | - G. S. Sanches
- Laboratory of Malaria Research, Oswaldo Cruz Institute (IOC/Fiocruz), Reference Center for Malaria Research, Diagnosis and Training, Rio de Janeiro, Brazil
| | - H. S. Borges
- Department of Chemistry, Center of Nanotechnology and Tissue Engineering - Photobiology and Photomedicine Research Group, Faculty of Philosophy, Sciences and Letters, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - L. A. U. Takahashi
- Department of Chemistry, Center of Nanotechnology and Tissue Engineering - Photobiology and Photomedicine Research Group, Faculty of Philosophy, Sciences and Letters, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - C. T. Daniel-Ribeiro
- Laboratory of Malaria Research, Oswaldo Cruz Institute (IOC/Fiocruz), Reference Center for Malaria Research, Diagnosis and Training, Rio de Janeiro, Brazil
| | - A. C. Tedesco
- Department of Chemistry, Center of Nanotechnology and Tissue Engineering - Photobiology and Photomedicine Research Group, Faculty of Philosophy, Sciences and Letters, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - J. W. L. Nascimento
- Department of Pharmacology (LaFaCE) - ICB, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Minas Gerais, Brazil
| | - L. J. M. Carvalho
- Laboratory of Malaria Research, Oswaldo Cruz Institute (IOC/Fiocruz), Reference Center for Malaria Research, Diagnosis and Training, Rio de Janeiro, Brazil
| |
Collapse
|
2
|
Marques I, Pires L, Bettencourt C, Gomes F, Almeida R, Ruivo Marques D, Allen Gomes A. Evening screen time, sleep and diurnal type in preschool and primary school children. Sleep Med 2022. [DOI: 10.1016/j.sleep.2022.05.222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
3
|
Banna G, Addeo A, Battisti N, Bambury K, Musolino N, O’Carroll E, Cantale O, Haydock M, Gomes F. International survey of frailty assessment in patients with cancer. J Geriatr Oncol 2021. [DOI: 10.1016/s1879-4068(21)00466-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
4
|
Mialon M, Vandevijvere S, Carriedo A, Bero L, Gomes F, Petticrew M, McKee M, Stuckler D, Sacks G. Mechanisms for addressing the influence of corporations on public health. Eur J Public Health 2021. [DOI: 10.1093/eurpub/ckab164.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Manufacturers, such as producers of cigarettes, drugs or ultra-processed foods, influence health policy, research and practice. This influence is one of the main barriers against the implementation of public health policies around the world. Our goal was to identify existing mechanisms to limit this influence.
Methods
We conducted a scoping review in 2019. We searched five scientific databases: Web of Science Core Collection; BIOSIS; MEDLINE; Base; Scopus. Twenty-eight institutions and networks related to our research objective were also contacted to identify additional mechanisms and examples. In addition, we identified mechanisms and examples drawn from our collective experience. We have classified the mechanisms into two groups: those of international organizations and governments; those for universities, the media and civil society.
Results
Thirty-one publications were included in our review, including eight scientific articles. Nine mechanisms focused on several industries; while the other documents targeted specific industries. We identified 49 mechanisms that could help limit corporate influence in health policy, science and practice. For 41 of these mechanisms, we found examples, around the world, where they have been implemented. The main objectives of the mechanisms identified were to manage conflicts of interest and ethical issues, while increasing the transparency of public-private interactions. Mechanisms for governments (n = 17) and universities (n = 13) were most frequently identified, with fewer examples existing to protect the media and civil society.
Discussion
The development, implementation and monitoring of these mechanisms are essential to protect public health from industrial influence.
Key messages
We found 49 mechanisms that could help limit corporate influence in health policy, science and practice. There are fewer mechanisms to protect the media and civil society, than to protect governments and universities.
Collapse
Affiliation(s)
- M Mialon
- Trinity College Dublin, Dublin, Ireland
| | | | - A Carriedo
- World Public Health Nutrition Association, London, UK
| | - L Bero
- University of California San Francisco, San Francisco, USA
| | - F Gomes
- Pan American Health Organization, Washington, USA
| | | | | | | | - G Sacks
- Deakin University, Burwood, Australia
| |
Collapse
|
5
|
Mendes-Oliveira F, Martins R, Souza VR, Gomes F, Bolina E, Ozahata M, Franco L, Carneiro-Proietti AB, Sabino E, Belisário AR. ANÁLISE DO MICROBIOMA EM ÚLCERA DE PERNA DE PACIENTES COM ANEMIA FALCIFORME. Hematol Transfus Cell Ther 2021. [DOI: 10.1016/j.htct.2021.10.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
6
|
Crockett C, Gomes F, Faivre-Finn C, Howell S, Kasipandian V, Smith E, Thomson D, Yorke J, Price J. The Routine Clinical Implementation of Electronic Patient-reported Outcome Measures (ePROMs) at The Christie NHS Foundation Trust. Clin Oncol (R Coll Radiol) 2021; 33:761-764. [PMID: 34229926 DOI: 10.1016/j.clon.2021.06.004] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2021] [Accepted: 06/03/2021] [Indexed: 11/27/2022]
Affiliation(s)
- C Crockett
- Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK
| | - F Gomes
- Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK
| | - C Faivre-Finn
- Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK
| | - S Howell
- Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK
| | - V Kasipandian
- Department of Critical Care and Anaesthesia, The Christie NHS Foundation Trust, Manchester, UK
| | - E Smith
- Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK
| | - D Thomson
- Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK
| | - J Yorke
- Christie Patient-Centred Research, Division of Nursing, Midwifery & Social Work, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK
| | - J Price
- Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK.
| |
Collapse
|
7
|
Bargetzi L, Brack C, Herrmann J, Bargetzi A, Hersberger L, Bargetzi M, Kaegi-Braun N, Tribolet P, Gomes F, Hoess C, Pavlicek V, Bilz S, Sigrist S, Brändle M, Henzen C, Thomann R, Rutishauser J, Aujesky D, Rodondi N, Donzé J, Laviano A, Stanga Z, Mueller B, Schuetz P. Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial. Ann Oncol 2021; 32:1025-1033. [PMID: 34022376 DOI: 10.1016/j.annonc.2021.05.793] [Citation(s) in RCA: 80] [Impact Index Per Article: 26.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Revised: 04/29/2021] [Accepted: 05/14/2021] [Indexed: 01/03/2023] Open
Abstract
BACKGROUND Nutritional support in patients with cancer aims at improving quality of life. Whether use of nutritional support is also effective in improving clinical outcomes requires further study. PATIENTS AND METHODS In this preplanned secondary analysis of patients with cancer included in a prospective, randomized-controlled, Swiss, multicenter trial (EFFORT), we compared protocol-guided individualized nutritional support (intervention group) to standard hospital food (control group) regarding mortality at 30-day (primary endpoint) and other clinical outcomes. RESULTS We analyzed 506 patients with a main admission diagnosis of cancer, including lung cancer (n = 113), gastrointestinal tumors (n = 84), hematological malignancies (n = 108) and other types of cancer (n = 201). Nutritional risk based on Nutritional Risk Screening (NRS 2002) was an independent predictor for mortality over 180 days with an (age-, sex-, center-, type of cancer-, tumor activity- and treatment-) adjusted hazard ratio of 1.29 (95% CI 1.09-1.54; P = 0.004) per point increase in NRS. In the 30-day follow-up period, 50 patients (19.9%) died in the control group compared to 36 (14.1%) in the intervention group resulting in an adjusted odds ratio of 0.57 (95% CI 0.35-0.94; P = 0.027). Interaction tests did not show significant differences in mortality across the cancer type subgroups. Nutritional support also significantly improved functional outcomes and quality of life measures. CONCLUSIONS Compared to usual hospital nutrition without nutrition support, individualized nutritional support reduced the risk of mortality and improved functional and quality of life outcomes in cancer patients with increased nutritional risk. These data further support the inclusion of nutritional care in cancer management guidelines.
Collapse
Affiliation(s)
- L Bargetzi
- Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Medical Faculty of the University of Basel, Basel, Switzerland
| | - C Brack
- Medical Faculty of the University of Basel, Basel, Switzerland
| | - J Herrmann
- Medical Faculty of the University of Basel, Basel, Switzerland
| | - A Bargetzi
- Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Medical Faculty of the University of Basel, Basel, Switzerland
| | - L Hersberger
- Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Medical Faculty of the University of Basel, Basel, Switzerland
| | - M Bargetzi
- Medical Faculty of the University of Basel, Basel, Switzerland; Division of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland
| | - N Kaegi-Braun
- Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland
| | - P Tribolet
- Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Department of Health Professions, Bern University of Applied Sciences, Bern, Switzerland
| | - F Gomes
- Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; The New York Academy of Sciences, New York, USA
| | - C Hoess
- Internal Medicine, Kantonsspital Muensterlingen, Muensterlingen, Switzerland
| | - V Pavlicek
- Internal Medicine, Kantonsspital Muensterlingen, Muensterlingen, Switzerland
| | - S Bilz
- Internal Medicine & Endocrinology/Diabetes, Kantonsspital St.Gallen, St.Gallen, Switzerland
| | - S Sigrist
- Internal Medicine & Endocrinology/Diabetes, Kantonsspital St.Gallen, St.Gallen, Switzerland
| | - M Brändle
- Internal Medicine & Endocrinology/Diabetes, Kantonsspital St.Gallen, St.Gallen, Switzerland
| | - C Henzen
- Internal Medicine, Kantonsspital Luzern, Luzern, Switzerland
| | - R Thomann
- Internal Medicine, Buergerspital Solothurn, Solothurn, Switzerland
| | - J Rutishauser
- Internal Medicine, Kantonsspital Baselland, Liestal, Switzerland
| | - D Aujesky
- Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - N Rodondi
- Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
| | - J Donzé
- Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Division of General Internal Medicine, Brigham and Women's Hospital, Boston, USA
| | - A Laviano
- Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
| | - Z Stanga
- Division of Diabetes, Endocrinology, Nutritional Medicine & Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - B Mueller
- Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Medical Faculty of the University of Basel, Basel, Switzerland
| | - P Schuetz
- Medical University Department, Division of General Internal and Emergency Medicine, Kantonsspital Aarau, Aarau, Switzerland; Medical Faculty of the University of Basel, Basel, Switzerland.
| |
Collapse
|
8
|
Lee RJ, Wysocki O, Bhogal T, Shotton R, Tivey A, Angelakas A, Aung T, Banfill K, Baxter M, Boyce H, Brearton G, Copson E, Dickens E, Eastlake L, Gomes F, Hague C, Harrison M, Horsley L, Huddar P, Hudson Z, Khan S, Khan UT, Maynard A, McKenzie H, Palmer D, Robinson T, Rowe M, Thomas A, Tweedy J, Sheehan R, Stockdale A, Weaver J, Williams S, Wilson C, Zhou C, Dive C, Cooksley T, Palmieri C, Freitas A, Armstrong AC. Erratum to 'Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome': [ESMO Open Volume 6, Issue 1, February 2021, 100005]. ESMO Open 2021; 6:100056. [PMID: 33545518 PMCID: PMC7842131 DOI: 10.1016/j.esmoop.2021.100056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Affiliation(s)
- R J Lee
- The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.
| | - O Wysocki
- The University of Manchester, Manchester, UK; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK
| | - T Bhogal
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK
| | - R Shotton
- The Christie NHS Foundation Trust, Manchester, UK
| | - A Tivey
- The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK
| | - A Angelakas
- University Hospitals of Morecambe Bay, Kendal, UK
| | - T Aung
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - K Banfill
- The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK
| | - M Baxter
- University of Dundee, Dundee, UK
| | - H Boyce
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - G Brearton
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK
| | - E Copson
- Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - E Dickens
- Leicester Cancer Research Centre, University of Leicester, Leicester, UK
| | - L Eastlake
- University Hospitals Plymouth NHS Trust, Plymouth, UK
| | - F Gomes
- The Christie NHS Foundation Trust, Manchester, UK
| | - C Hague
- The Christie NHS Foundation Trust, Manchester, UK
| | | | - L Horsley
- The Christie NHS Foundation Trust, Manchester, UK
| | - P Huddar
- Lancashire Teaching Hospitals NHS Trust, Preston, UK
| | - Z Hudson
- Bristol Haematology and Oncology Centre, Bristol, UK
| | - S Khan
- Leicester Cancer Research Centre, University of Leicester, Leicester, UK; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, UK
| | - U T Khan
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK
| | - A Maynard
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - H McKenzie
- Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - D Palmer
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK
| | - T Robinson
- Bristol Haematology and Oncology Centre, Bristol, UK; Sunrise Oncology Centre, Royal Cornwall Hospital, Truro, UK
| | - M Rowe
- National Institute for Biological Standards and Control, Potters Bar, UK
| | - A Thomas
- Leicester Cancer Research Centre, University of Leicester, Leicester, UK; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, UK
| | - J Tweedy
- Institute of Infection and Global Health, University of Liverpool and Tropical and Infectious Diseases Unit, Royal Liverpool Hospital, Liverpool, UK
| | - R Sheehan
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - A Stockdale
- Cancer Research UK Manchester Institute, Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK
| | - J Weaver
- The Christie NHS Foundation Trust, Manchester, UK
| | - S Williams
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - C Wilson
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - C Zhou
- The University of Bristol, Bristol, UK
| | - C Dive
- The University of Bristol, Bristol, UK
| | - T Cooksley
- The Christie NHS Foundation Trust, Manchester, UK
| | - C Palmieri
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK
| | - A Freitas
- The University of Manchester, Manchester, UK; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK
| | - A C Armstrong
- The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK
| |
Collapse
|
9
|
Lee RJ, Wysocki O, Bhogal T, Shotton R, Tivey A, Angelakas A, Aung T, Banfill K, Baxter M, Boyce H, Brearton G, Copson E, Dickens E, Eastlake L, Gomes F, Hague C, Harrison M, Horsley L, Huddar P, Hudson Z, Khan S, Khan UT, Maynard A, McKenzie H, Palmer D, Robinson T, Rowe M, Thomas A, Tweedy J, Sheehan R, Stockdale A, Weaver J, Williams S, Wilson C, Zhou C, Dive C, Cooksley T, Palmieri C, Freitas A, Armstrong AC. Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome. ESMO Open 2021; 6:100005. [PMID: 33399072 PMCID: PMC7808077 DOI: 10.1016/j.esmoop.2020.100005] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2020] [Revised: 10/16/2020] [Accepted: 11/02/2020] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND Cancer patients are at increased risk of death from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cancer and its treatment affect many haematological and biochemical parameters, therefore we analysed these prior to and during coronavirus disease 2019 (COVID-19) and correlated them with outcome. PATIENTS AND METHODS Consecutive patients with cancer testing positive for SARS-CoV-2 in centres throughout the United Kingdom were identified and entered into a database following local governance approval. Clinical and longitudinal laboratory data were extracted from patient records. Data were analysed using Mann-Whitney U test, Fisher's exact test, Wilcoxon signed rank test, logistic regression, or linear regression for outcomes. Hierarchical clustering of heatmaps was performed using Ward's method. RESULTS In total, 302 patients were included in three cohorts: Manchester (n = 67), Liverpool (n = 62), and UK (n = 173). In the entire cohort (N = 302), median age was 69 (range 19-93 years), including 163 males and 139 females; of these, 216 were diagnosed with a solid tumour and 86 with a haematological cancer. Preinfection lymphopaenia, neutropaenia and lactate dehydrogenase (LDH) were not associated with oxygen requirement (O2) or death. Lymphocyte count (P < 0.001), platelet count (P = 0.03), LDH (P < 0.0001) and albumin (P < 0.0001) significantly changed from preinfection to during infection. High rather than low neutrophils at day 0 (P = 0.007), higher maximal neutrophils during COVID-19 (P = 0.026) and higher neutrophil-to-lymphocyte ratio (NLR; P = 0.01) were associated with death. In multivariable analysis, age (P = 0.002), haematological cancer (P = 0.034), C-reactive protein (P = 0.004), NLR (P = 0.036) and albumin (P = 0.02) at day 0 were significant predictors of death. In the Manchester/Liverpool cohort 30 patients have restarted therapy following COVID-19, with no additional complications requiring readmission. CONCLUSION Preinfection biochemical/haematological parameters were not associated with worse outcome in cancer patients. Restarting treatment following COVID-19 was not associated with additional complications. Neutropaenia due to cancer/treatment is not associated with COVID-19 mortality. Cancer therapy, particularly in patients with solid tumours, need not be delayed or omitted due to concerns that treatment itself increases COVID-19 severity.
Collapse
Affiliation(s)
- R J Lee
- The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK; Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.
| | - O Wysocki
- The University of Manchester, Manchester, UK; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK
| | - T Bhogal
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK
| | - R Shotton
- The Christie NHS Foundation Trust, Manchester, UK
| | - A Tivey
- The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK
| | - A Angelakas
- University Hospitals of Morecambe Bay, Kendal, UK
| | - T Aung
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - K Banfill
- The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK
| | - M Baxter
- University of Dundee, Dundee, UK
| | - H Boyce
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - G Brearton
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK
| | - E Copson
- Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - E Dickens
- Leicester Cancer Research Centre, University of Leicester, Leicester, UK
| | - L Eastlake
- University Hospitals Plymouth NHS Trust, Plymouth, UK
| | - F Gomes
- The Christie NHS Foundation Trust, Manchester, UK
| | - C Hague
- The Christie NHS Foundation Trust, Manchester, UK
| | | | - L Horsley
- The Christie NHS Foundation Trust, Manchester, UK
| | - P Huddar
- Lancashire Teaching Hospitals NHS Trust, Preston, UK
| | - Z Hudson
- Bristol Haematology and Oncology Centre, Bristol, UK
| | - S Khan
- Leicester Cancer Research Centre, University of Leicester, Leicester, UK; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, UK
| | - U T Khan
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK
| | - A Maynard
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - H McKenzie
- Cancer Sciences Academic Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - D Palmer
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK
| | - T Robinson
- Bristol Haematology and Oncology Centre, Bristol, UK; Sunrise Oncology Centre, Royal Cornwall Hospital, Truro, UK
| | - M Rowe
- National Institute for Biological Standards and Control, Potters Bar, UK
| | - A Thomas
- Leicester Cancer Research Centre, University of Leicester, Leicester, UK; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, UK
| | - J Tweedy
- Institute of Infection and Global Health, University of Liverpool and Tropical and Infectious Diseases Unit, Royal Liverpool Hospital, Liverpool, UK
| | - R Sheehan
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - A Stockdale
- Cancer Research UK Manchester Institute, Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK
| | - J Weaver
- The Christie NHS Foundation Trust, Manchester, UK
| | - S Williams
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - C Wilson
- Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
| | - C Zhou
- The University of Bristol, Bristol, UK
| | - C Dive
- The University of Bristol, Bristol, UK
| | - T Cooksley
- The Christie NHS Foundation Trust, Manchester, UK
| | - C Palmieri
- The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; The University of Liverpool, Liverpool, UK
| | - A Freitas
- The University of Manchester, Manchester, UK; Digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, UK
| | - A C Armstrong
- The Christie NHS Foundation Trust, Manchester, UK; The University of Manchester, Manchester, UK
| |
Collapse
|
10
|
Gomes F, Lorigan P, Woolley S, Foden P, Burns K, Yorke J, Blackhall F. A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients - the ELDERS study. ESMO Open 2021; 6:100042. [PMID: 33516147 PMCID: PMC7844568 DOI: 10.1016/j.esmoop.2020.100042] [Citation(s) in RCA: 44] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2020] [Revised: 12/06/2020] [Accepted: 12/20/2020] [Indexed: 11/30/2022] Open
Abstract
Objective Older cancer patients are underrepresented in the pivotal trials of checkpoint inhibitors (CPIs). This study aimed to investigate the impact of an ageing immune system on CPI-related toxicity and provide evidence for the role of geriatric assessments with CPI. Methods The ELDERS study is a prospective observational study with two cohorts: older (70+ years of age) and younger (<70 years of age). Patients with advanced/metastatic non-small-cell lung cancer or melanoma starting single-agent CPI were eligible. The older cohort was assessed for frailty with Geriatric-8 (G8) screening, which when positive (<15 points) was followed by a holistic set of geriatric assessments. Primary endpoint was the incidence of grade 3-5 immune-related adverse events (irAEs). Results One hundred and forty patients were enrolled with 43% being pretreated and pembrolizumab represented 92% of treatments on study. The older cohort had a significantly higher comorbidity burden (P < 0.001) and polypharmacy (P = 0.004). While 50% of older patients had a positive G8 screening, 60% on this frail subgroup had a performance status score of 0 or 1. There was no significant difference in the incidence of irAEs grade 3-5 between older and younger cohorts (18.6% versus 12.9%; odds ratio 1.55, confidence interval 95% 0.61-3.89; P = 0.353). Exposure to systemic steroids due to irAEs was numerically longer for older patients (22 versus 8 weeks; P = 0.208). A positive G8 screening predicted hospital admissions (P = 0.031) and risk of death (P = 0.01). Conclusions The use of CPI in older patients was not associated with more high-grade toxicity. The G8 screening identified a subgroup with higher risk of AEs and its implementation should be considered in the context of CPI. The ELDERS is the first prospective study designed to address the safety of immunotherapy in older cancer patients. Older cancer patients had no increased risk of high-grade toxicity with immunotherapy. Management of immune toxicity in older patients is often more challenging, particularly for those more vulnerable/frail. Geriatric assessments in the context of immunotherapy predict clinical outcomes. Comorbidity burden, polypharmacy and the G8 screening identified those with worst outcomes.
Collapse
Affiliation(s)
- F Gomes
- Medical Oncology Department, The Christie NHS Foundation Trust, Manchester, UK; Patient-Centred Research Centre, The Christie NHS Foundation Trust, Manchester, UK.
| | - P Lorigan
- Medical Oncology Department, The Christie NHS Foundation Trust, Manchester, UK; Division of Medical Sciences, University of Manchester, Manchester, UK
| | - S Woolley
- Research & Innovation Department, The Christie NHS Foundation Trust, Manchester, UK
| | - P Foden
- Data Analytics Department, The Christie NHS Foundation Trust, Manchester, UK
| | - K Burns
- Research & Innovation Department, The Christie NHS Foundation Trust, Manchester, UK
| | - J Yorke
- Patient-Centred Research Centre, The Christie NHS Foundation Trust, Manchester, UK; Division of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK
| | - F Blackhall
- Medical Oncology Department, The Christie NHS Foundation Trust, Manchester, UK; Division of Medical Sciences, University of Manchester, Manchester, UK
| |
Collapse
|
11
|
Lim KHJ, Gomes F. ESMO20 YO for YO: highlights on oncogene-addicted NSCLC. ESMO Open 2020; 6:100026. [PMID: 33399088 PMCID: PMC7807911 DOI: 10.1016/j.esmoop.2020.100026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Affiliation(s)
- K H J Lim
- Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Immunology and Inflammation, Imperial College London, London, UK.
| | - F Gomes
- Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
| |
Collapse
|
12
|
Tivey A, Shotton R, Lee R, Zhou C, Banfill K, Hague C, Gomes F, Weaver J, Armstrong A, Cooksley T. 1722P Longitudinal analysis of biochemical and haematological features of cancer patients with COVID-19. Ann Oncol 2020. [PMCID: PMC7506351 DOI: 10.1016/j.annonc.2020.08.1786] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
13
|
Nascimento M, Lourenço B, Coelho I, Aguiar J, Lázaro M, Silva M, Pereira C, Neves-Caldas I, Gomes F, Garcia S, Nascimento S, Pereira G, Nogueira V, Costa P, Nobre A. No man is an island: spatial clustering and access to primary care as possible targets for the development of new community mental health approaches. BMC Health Serv Res 2020; 20:344. [PMID: 32321489 PMCID: PMC7178966 DOI: 10.1186/s12913-020-05190-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Accepted: 04/06/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND to understand if patients seen at Centro Hospitalar Psiquiátrico de Lisboa (CHPL) live in geographical clusters or randomly throughout the city, as well as determine their access to the psychiatric hospital and primary care facilities (PCF). METHODS spatial autocorrelation statistics were performed (queen criterion of contiguity), regarding all patients observed at CHPL in 2017 (at the census subsection level), and considering not only their overall number but also main diagnosis, and admission to the psychiatric ward - voluntary or compulsory. Distance to the hospital and to the closest PCF was measured (for each patient and the variables cited above), and the mean values were compared. Finally, the total number of patients around each PCF was counted, considering specified radius sizes of 656 and 1000 m. RESULTS All 5161 patients (509 psychiatric admissions) were geolocated, and statistical significance regarding patient clustering was found for the total number (p-0.0001) and specific group of disorders, namely Schizophrenia and related disorders (p-0.007) and depressive disorders (p-0.0002). Patients who were admitted in a psychiatric ward live farther away from the hospital (p-0.002), with the compulsory admissions (versus voluntary ones) living even farther (p-0.004). Furthermore, defining a radius of 1000 m for each PCF allowed the identification of two PCF with more than 1000 patients, and two others with more than 800. CONCLUSIONS as patients seem to live in geographical clusters (and considering PCFs with the highest number of them), possible locations for the development of programs regarding mental health treatment and prevention can now be identified.
Collapse
Affiliation(s)
- M Nascimento
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal.
| | - B Lourenço
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - I Coelho
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - J Aguiar
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - M Lázaro
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - M Silva
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - C Pereira
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - I Neves-Caldas
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - F Gomes
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - S Garcia
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - S Nascimento
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - G Pereira
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - V Nogueira
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - P Costa
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| | - A Nobre
- Centro Hospitalar Psiquiátrico de Lisboa, Avenida do Brasil 53, Lisbon, Portugal
| |
Collapse
|
14
|
Scotté F, Bossi P, Carola E, Cudennec T, Dielenseger P, Gomes F, Knox S, Strasser F. Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide. Ann Oncol 2019; 29:1718-1726. [PMID: 30010772 DOI: 10.1093/annonc/mdy228] [Citation(s) in RCA: 84] [Impact Index Per Article: 16.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
Around 60% of people living with cancer are aged 65 years or older. Older cancer patients face a unique set of age-associated changes, comorbidities and circumstances that impact on their quality of life (QoL) in ways that are different from those affecting younger patients. A Task Force of the International Society of Geriatric Oncology recommends and encourages all healthcare professionals involved in cancer care to place greater focus on the QoL of older people living with cancer. This paper summarizes current thinking on the key issues of importance to addressing QoL needs of older cancer patients and makes a series of recommendations, together with practical guidance.
Collapse
Affiliation(s)
- F Scotté
- Department of Medical Oncology and Supportive Care, Foch Hospital, Suresnes, France.
| | - P Bossi
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - E Carola
- Groupe Hospitalier Public Sud de L'Oise, Creil, France
| | - T Cudennec
- Service de Médecine Gériatrique, HU-PIFO site Ambroise Paré, AP-HP, Boulogne Billancourt, France
| | - P Dielenseger
- Département des Innovations Thérapeutiques et Essais Précoces, Gustave Roussy Cancer Campus, French Oncology Nursing Society, Paris, France
| | - F Gomes
- Medical Oncology Department, The Christie Hospital NHS Foundation Trust, Manchester, UK
| | - S Knox
- EUROPA DONNA - The European Breast Cancer Coalition, Milan, Italy
| | - F Strasser
- Oncological Palliative Medicine, Clinic Medical Oncology and Hematology, Department of Internal Medicine, Cantonal Hospital St Gallen, St Gallen, Switzerland
| |
Collapse
|
15
|
Califano R, Gomes F, Ackermann CJ, Rafee S, Tsakonas G, Ekman S. Immune checkpoint blockade for non-small cell lung cancer: What is the role in the special populations? Eur J Cancer 2019; 125:1-11. [PMID: 31830688 DOI: 10.1016/j.ejca.2019.11.010] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2019] [Revised: 10/05/2019] [Accepted: 11/06/2019] [Indexed: 02/06/2023]
Abstract
In recent years, non-small cell lung cancer (NSCLC) entered in a new era of anticancer treatments with the success of checkpoint inhibitors (CPIs). These are now part of daily practice from locally advanced to metastatic NSCLC. However, the registration phase III trials are highly selective and not fully representative of the patients seen in real-world clinical practice. This is particularly obvious for older and frail patients, which represent the majority of NSCLC cases worldwide. The median age of the patients enrolled in clinical trials is 10 years younger than what is seen in clinic and patients with performance status (PS) ≥2 were excluded from registration studies. No strong conclusions can be drawn from the available trials where older and frail patients have been excluded. The majority of data on efficacy according to age are derived from underpowered subgroup analysis and there are no age-specific safety data published. Current data suggest that older patients may derive a similar benefit with no increased toxicity when compared with younger patients. However, the recent development of immunotherapychemotherapy combinations and the potential higher incidence of toxicity, raise additional concerns for these populations where adequate patient selection is paramount. CPI is not recommended for patients with PS 3-4 and should be considered with caution for those with PS 2. The evidence for patients with pre-existing autoimmune disease (AID), organ transplant or chronic viral infections (such us viral hepatitis B and C or human immunodeficiency virus) is less clear and low level. Although CPI are potentially safe in selected patients with AID with minimal activity and well-controlled chronic viral infections, patients with solid organ transplant face a significant risk of graft loss and death. Therefore, a decision to treat these groups of patients should always be discussed at a multidisciplinary level.
Collapse
Affiliation(s)
- R Califano
- Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, Manchester, UK.
| | - F Gomes
- Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
| | - C J Ackermann
- Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
| | - S Rafee
- Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
| | - G Tsakonas
- Department of Oncology-Pathology, Karolinska Institutet/Theme Cancer, Karolinska University Hospital, Stockholm, Sweden
| | - S Ekman
- Department of Oncology-Pathology, Karolinska Institutet/Theme Cancer, Karolinska University Hospital, Stockholm, Sweden
| |
Collapse
|
16
|
Gomes F, Baker K, Woods J, Bruce J, Eaton M, Higham P, Cove-Smith L, Garbett A, Cree A, Ng C, Blackhall F, Bayman N. MA19.09 Assessing Clinical Frailty in Advanced Lung Cancer Patients - An Opportunity to Improve Patient Outcomes? J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.661] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
17
|
Gomes F, Tokaca N, Yip K, Ghosh S, Newsom-Davis T, Greystoke A, Mills H, Ahmed S, Harle A, Ayre G, Shah R, Popat S, Blackhall F, Summers Y. Brigatinib experience on the ALK project. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz063.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
18
|
Gomes F, Watanabe L, Vianez J, Nunes M, Cardoso J, Lima C, Schneider H, Sampaio I. Comparative analysis of the transcriptome of the Amazonian fish species Colossoma macropomum (tambaqui) and hybrid tambacu by next generation sequencing. PLoS One 2019; 14:e0212755. [PMID: 30802266 PMCID: PMC6388931 DOI: 10.1371/journal.pone.0212755] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2018] [Accepted: 02/10/2019] [Indexed: 12/13/2022] Open
Abstract
Background The C. macropomum is a characiform fish from the Amazon basin that has been hybridized with other pacu species to produce commercial hybrids, such as the tambacu. However, little is known of the functional genomics of the parental species or these hybrid forms. The transcriptome of C. macropomum and tambacu were sequenced using 454 Roche platform (pyrosequencing) techniques to characterize the domains of Gene Ontology (GO) and to evaluate the levels of gene expression in the two organisms. Results The 8,188,945 reads were assembled into 400,845 contigs. A total of 58,322 contigs were annotated with a predominance of biological processes for both organisms, as determined by Gene Ontology (GO). Similar numbers of metabolic pathways were identified in both the C. macropomum and the tambacu, with the metabolism category presenting the largest number of transcripts. The BUSCO analysis indicated that our assembly was more than 40% complete. We identified 21,986 genes for the two fishes. The P and Log2FC values indicated significant differences in the levels of gene expression, with a total of 600 up-regulated genes. Conclusion In spite of the lack of a reference genome, the functional annotation was successful, and confirmed a considerable difference in the specificity and levels of gene expression between the two organisms. This report provides a comprehensive baseline for the genetic management of these commercially important fishes, in particular for the identification of specific genes that may represent markers involved in the immunity, growth, and fertility of these organisms, with potential practical applications in aquaculture management.
Collapse
Affiliation(s)
- Fátima Gomes
- Institute of Coastal Studies, Laboratory of Genetics and Molecular Biology, Universidade Federal do Pará, Campus de Bragança, Alameda Leandro Ribeiro, Bragança, PA, Brazil
- * E-mail:
| | - Luciana Watanabe
- Institute of Coastal Studies, Laboratory of Genetics and Molecular Biology, Universidade Federal do Pará, Campus de Bragança, Alameda Leandro Ribeiro, Bragança, PA, Brazil
| | - João Vianez
- Center for Technological Innovation, Evandro Chagas Institute, Ministry of Health, Ananindeua, PA, Brazil
| | - Márcio Nunes
- Center for Technological Innovation, Evandro Chagas Institute, Ministry of Health, Ananindeua, PA, Brazil
| | - Jedson Cardoso
- Center for Technological Innovation, Evandro Chagas Institute, Ministry of Health, Ananindeua, PA, Brazil
- Postgraduate Program in Virology (PPGV), Evandro Chagas Institute, Ministry of Health, Ananindeua, PA, Brazil
| | - Clayton Lima
- Center for Technological Innovation, Evandro Chagas Institute, Ministry of Health, Ananindeua, PA, Brazil
| | - Horacio Schneider
- Institute of Coastal Studies, Laboratory of Genetics and Molecular Biology, Universidade Federal do Pará, Campus de Bragança, Alameda Leandro Ribeiro, Bragança, PA, Brazil
| | - Iracilda Sampaio
- Institute of Coastal Studies, Laboratory of Genetics and Molecular Biology, Universidade Federal do Pará, Campus de Bragança, Alameda Leandro Ribeiro, Bragança, PA, Brazil
| |
Collapse
|
19
|
Gomes F, Yip K, Tokaca N, Greystoke A, Escriu C, Conibear J, Ghosh S, Doherty G, Funingana I, Ahmad T, Ahmed S, Cox R, Newsom-Davis T, Mills H, Shah R, Dorey N, Harle A, Dancey G, Baijal S, Geldart T, Ghafoor Q, Tarver K, Talbot T, Forster M, Cove-Smith L, Califano R, Blackhall F, Popat S, Summers Y. The ALK project: a real-world national network and database. Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30121-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
20
|
Tokaca N, Gomes F, Lau S, Jackson A, Gradwell M, Gyi M, Reinius M, Valentine E, Winn E, Bhosle J, O’Brien M, Yousaf N, Blackhall F, Gilligan D, Treece S, Yip K, Geldart T, Baluch S, Gulliford T, Muthuramalingam S, Dancey G, Britten A, Brock J, Stokoe J, Jain P, Franks K, Toy E, Newsom-Davis T, Khan O, Greystoke A, Ali C, Leonard P, Summers Y, Popat S. Real-world outcomes with pembrolizumab in patients with treatment-naive advanced/metastatic NSCLC in the UK: multicentre retrospective observational study. Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30124-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
21
|
Tivey A, Wu K, Tay R, Gomes F, Taylor P, Blackhall F, Summers Y, Califano R, Cove-Smith L. Pembrolizumab monotherapy for advanced/recurrent non-small cell lung cancer: a Greater Manchester experience. Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30150-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
22
|
Watanabe L, Gomes F, Vianez J, Nunes M, Cardoso J, Lima C, Schneider H, Sampaio I. De novo transcriptome based on next-generation sequencing reveals candidate genes with sex-specific expression in Arapaima gigas (Schinz, 1822), an ancient Amazonian freshwater fish. PLoS One 2018; 13:e0206379. [PMID: 30372461 PMCID: PMC6205615 DOI: 10.1371/journal.pone.0206379] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2018] [Accepted: 10/11/2018] [Indexed: 12/24/2022] Open
Abstract
Background The Arapaima (Arapaima gigas) is one of the world's largest freshwater bony fish, and is found in the rivers of the Amazon basin. This species is a potential aquaculture resource, although reproductive management in captivity is limited in particular due to the lack of external sexual dimorphism. In this study, using the 454 Roche platform (pyrosequencing) techniques, we evaluated a major portion of the transcriptome of this important Amazonian species. Results Four libraries obtained from the liver and skin tissue of juvenile specimens (representing males and females separately) were sequenced, yielding 5,453,919 high-quality reads. The de novo transcriptome assembly resulted in 175,792 contigs, with 51,057 significant blast hits. A total of 38,586 transcripts were mapped by Gene Ontology using Blast2GO. We identified 20,219 genes in the total transcriptome (9,551 in the liver and 16,818 in the skin). The gene expression analyses indicated 105 genes in the liver and 204 in the skin with differentiated expression profiles, with 95 being over-expressed in the females and 214 in the males. The log2 Fold Change and heatmap based on Reads Per Kilobase per Million mapped reads (RPKM) revealed that the gene expression in the skin is highly differentiated between male and female arapaima, while the levels of expression in the liver are similar between the sexes. Conclusion Transcriptome analysis based on pyrosequencing proved to be a reliable tool for the identification of genes with differentiated expression profiles between male and female arapaima. These results provide useful insights into the molecular pathways of sexual dimorphism in this important Amazonian species, and for comparative analyses with other teleosts.
Collapse
Affiliation(s)
- Luciana Watanabe
- Laboratório de Genética e Biologia Molecular, Instituto de Estudos Costeiros (IECOS), Universidade Federal do Pará, Campus de Bragança, Pará, Brazil
- * E-mail:
| | - Fátima Gomes
- Laboratório de Genética e Biologia Molecular, Instituto de Estudos Costeiros (IECOS), Universidade Federal do Pará, Campus de Bragança, Pará, Brazil
| | - João Vianez
- Centro de Inovações Tecnológicas (CIT), Instituto Evandro Chagas (IEC), Ananindeua, Pará, Brazil
| | - Márcio Nunes
- Centro de Inovações Tecnológicas (CIT), Instituto Evandro Chagas (IEC), Ananindeua, Pará, Brazil
| | - Jedson Cardoso
- Centro de Inovações Tecnológicas (CIT), Instituto Evandro Chagas (IEC), Ananindeua, Pará, Brazil
| | - Clayton Lima
- Centro de Inovações Tecnológicas (CIT), Instituto Evandro Chagas (IEC), Ananindeua, Pará, Brazil
| | - Horacio Schneider
- Laboratório de Genética e Biologia Molecular, Instituto de Estudos Costeiros (IECOS), Universidade Federal do Pará, Campus de Bragança, Pará, Brazil
| | - Iracilda Sampaio
- Laboratório de Genética e Biologia Molecular, Instituto de Estudos Costeiros (IECOS), Universidade Federal do Pará, Campus de Bragança, Pará, Brazil
| |
Collapse
|
23
|
Santos S, Rodrigo A, Gomes F. Is quality of life a priority in Portugal? Assessing the quality of life of adults with intellectual disability and higher support needs. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.1273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
24
|
Jamoulle M, Roland M, Bae JM, Heleno B, Visentin G, Gusso G, Godycki-Cwirko M, Pizzanelli M, Ouvrard P, La Vallev R, Gomes F, Widmer D, Bernstein J, Marino M, Lima Wagner H, Rossi I. [Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention]. Rev Med Brux 2018; 39:383-393. [PMID: 30321004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The concept of quaternary prevention, resulting from a reflection on the doctor-patient relationship, is presented as a renewal of the ageold ethical requirement: first, a doctor must not harm; second, the doctor must control himself/herself. The origin of the concept, its endorsement by the World Organization of Family Doctors (WONCA) and the European Union of General Practitioners (UEMO), its dissemination, and the debates to which it has given rise, are presented by a panel of authors from 12 countries and 3 continents. This collective text deals more specifically with the ethics of prevention, the importance of teaching Quaternary prevention and Evidence Based Medicine, the social and political implications of the concept of quaternary prevention, and its anthropological dimensions.
Collapse
Affiliation(s)
- M Jamoulle
- Université de Liège (ULg), Belgique
- Université Isalud, Buenos Aires, Argentine
| | - M Roland
- Université libre de Bruxelles (ULB)
- Président de Médecins du Monde
| | - J M Bae
- Département de médecine préventive. Université nationale de Jeju, Corée du Sud
| | - B Heleno
- Université Nouvelle de Lisbonne, USF das Conchas, Portugal
| | - G Visentin
- Centro Studi e Ricerche in Medicina generale, Milan, Italie
| | - G Gusso
- Département de Soins primaires, Université de São Paulo, Brésil
| | - M Godycki-Cwirko
- Faculté des Sciences Médicales, Université médicale de Lodz, Pologne
| | - M Pizzanelli
- Département de Médecine familiale, Université de la République (UDELAR), Florida, Uruguay
- Président du Groupe d'Intérêt spécial de la WONCA sur la Prévention quaternaire et la Surmédicalisation
| | - P Ouvrard
- Direction de la Recherche. Société de Formation et de Thérapeutique généraliste (SFTG), Paris, France
- Vice-Président de l'Union européenne des Médecins généralistes (UEMO)
| | - R La Vallev
- Département de Médecine familiale, Université de Buenos Aires
- Université nationale de Hurlingham, Argentine
| | - F Gomes
- Faculté de Médecine, Université d'Algarve, Faro, Portugal
| | - D Widmer
- Département de Médecine familiale, Université de Lausanne, Suisse
- Vice-Président de l'Union européenne des Médecins généralistes (UEMO)
| | - J Bernstein
- Président de la Commission de Prévention quaternaire de la Fédération argentine de Médecine générale et familiale (FAMFyG)
- Président du Chapitre Prévention quaternaire de l'Association des Psychiatres d'Argentine, Buenos Aires, Argentine
| | - M Marino
- Société argentine de Médecine Interne (SAMIG), Buenos Aires, Argentine
| | - H Lima Wagner
- Précepteur du Programme de Résidence en Médecine familiale et communautaire au Secrétariat de la Santé de Curitiba, Brésil
| | - I Rossi
- Institut des Sciences sociales, Faculté des Sciences sociales et politiques, Université de Lausanne (UNIL), Suisse
| |
Collapse
|
25
|
Gomes F, Woolley S, Califano R, Summers Y, Baker K, Burns K, Yorke J, Blackhall F. MA 10.07 Elderly Lung Cancer Patients on Immunotherapy: Preliminary Results from the ELDERS Study. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.538] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
26
|
Gomes F, Faivre-Finn C, Fernandez-Gutierrez F, Ryder D, Bezjak A, Cardenal F, Fournel P, Van Meerbeeck J, Blackhall F. Use of G-CSF and prophylactic antibiotics with concurrent chemo-radiotherapy in limited-stage small cell lung cancer: Results from the Phase III CONVERT trial. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx195.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
27
|
Gomes F, Clemente M, Figueiredo P, Plácito F, Machado H, Santos C, Costa R. Castanea spp. hybrid clones in vitro conservation: synthetic seeds vs. slow growth storage. ACTA ACUST UNITED AC 2017. [DOI: 10.17660/actahortic.2017.1155.4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
28
|
Gomes F, Watanabe L, Nozawa S, Oliveira L, Cardoso J, Vianez J, Nunes M, Schneider H, Sampaio I. Identification and characterization of the expression profile of the microRNAs in the Amazon species Colossoma macropomum by next generation sequencing. Genomics 2017; 109:67-74. [PMID: 28192178 DOI: 10.1016/j.ygeno.2017.02.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2016] [Revised: 02/06/2017] [Accepted: 02/08/2017] [Indexed: 01/20/2023]
Abstract
Colossoma macropomum is a resistant species native of Amazonas and Orinoco river basins. It is regarded as the second largest finfish of Solimões and Amazon rivers, representing a major fishery resource in Amazonas and an important species in tropical aquaculture. MicroRNAs are non-coding endogenous riboregulators of nearly 22 nucleotides that play a key role in post-transcriptional gene regulation of several organisms. We analyzed samples of liver and skin from specimens of C. macropomum using next generation sequencing. The dataset was evaluated using computational programs to check the quality of sequences, identification of miRNAs, as well as to evaluate the expression levels of these microRNAs and interaction of target genes. We identified 279 conserved miRNAs, being 257 from liver and 272 from skin, with several miRNAs shared between tissues, with divergence in the number of reads. The strands miR-5p and miR-3p were observed in 72 miRNAs, some of them presenting a higher number of 3p reads. The functional annotation of the most expressed miRNAs resulted in 27 pathways for the liver and skin mainly related to the "biological processes" domain. Based on the identified pathways, we visualized a large gene network, suggesting the regulation of selected miRNA over this interactive dataset. We were able to identify and characterize the expression levels of miRNAs in two tissues of great activity in C. macropomum, which stands out as the beginning of several studies that can be carried out to elucidate the influence of miRNAs in this species and their applicability as biotechnological tools.
Collapse
Affiliation(s)
- Fátima Gomes
- Institute of Coastal Studies, Laboratory of Genetics and Molecular Biology, Federal University of Pará, Campus of Bragança, 68600-000 Bragança, PA, Brazil.
| | - Luciana Watanabe
- Institute of Coastal Studies, Laboratory of Genetics and Molecular Biology, Federal University of Pará, Campus of Bragança, 68600-000 Bragança, PA, Brazil.
| | - Sérgio Nozawa
- Dow AgroSciences, Av Antonio Diederichsen, 400, - Ribeirão Preto, SP 14020-250, Brazil.
| | - Layanna Oliveira
- Center for Technological Innovation, Evandro Chagas Institute, Ministry of Health, 67030-000 Ananindeua, PA, Brazil.
| | - Jedson Cardoso
- Center for Technological Innovation, Evandro Chagas Institute, Ministry of Health, 67030-000 Ananindeua, PA, Brazil; Postgraduate Program in Virology (PPGV), Evandro Chagas Institute, Ministry of Health, Ananindeua, PA 67030-000, Brazil.
| | - João Vianez
- Center for Technological Innovation, Evandro Chagas Institute, Ministry of Health, 67030-000 Ananindeua, PA, Brazil.
| | - Márcio Nunes
- Center for Technological Innovation, Evandro Chagas Institute, Ministry of Health, 67030-000 Ananindeua, PA, Brazil.
| | - Horacio Schneider
- Institute of Coastal Studies, Laboratory of Genetics and Molecular Biology, Federal University of Pará, Campus of Bragança, 68600-000 Bragança, PA, Brazil.
| | - Iracilda Sampaio
- Institute of Coastal Studies, Laboratory of Genetics and Molecular Biology, Federal University of Pará, Campus of Bragança, 68600-000 Bragança, PA, Brazil.
| |
Collapse
|
29
|
Hookway C, Gomes F, Weekes CE. Royal College of Physicians Intercollegiate Stroke Working Party evidence-based guidelines for the secondary prevention of stroke through nutritional or dietary modification. J Hum Nutr Diet 2014; 28:107-25. [DOI: 10.1111/jhn.12248] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- C. Hookway
- Nutrition and Dietetics Department; Imperial College Healthcare NHS Trust; Charing Cross Hospital; London UK
| | - F. Gomes
- Diabetes and Nutritional Sciences Division; School of Medicine; King's College London; London UK
| | - C. E. Weekes
- Department of Nutrition & Dietetics; Guy's & St Thomas' NHS Foundation Trust; London UK
| |
Collapse
|
30
|
Chamney P, Moissl U, Wabel P, Amato C, Stuard S, Menzer M, Vollmeier C, Williams G, Shrivastava R, Chess J, Catling E, Brown C, Baker E, Ashcroft R, Mikhail A, Djukanovic L, Djuric Z, Knezevic V, Lazarevic T, Ljubenovic S, Markovic R, Rabrenovic V, Marinkovic J, Dimkovic N, Lebourg L, Ridel C, De Preneuf H, Le Roy F, Petitclerc T, Wester M, Simonis F, Kooman JP, Boer WH, Gerritsen KGF, Joles JA, Yamamoto KI, Eguchi K, Hirakawa S, Murakami J, Akiba T, Mineshima M, Stamopoulos D, Mpakirtzi N, Lavranos A, Panagiotou M, Barbarousi D, Matsouka C, Grapsa E, Abbas SR, Zhu F, Kaysen GA, Kotanko P, Levin NW, Vasilevsky A, Konoplev G, Stepanova O, Rubinsky A, Zemchenkov A, Gerasimchuk R, Frorip A, Abe T, Yamamoto KI, Ishimori I, Eguchi K, Murakami J, Mineshima M, Akiba T, Kusztal M, Go Biowski, T, Letachowicz K, Koni Ski P, Witkowski G, Pozna Ski P, Weyde W, Klinger M, Ito M, Ito S, Suzuki M, Masakane I, Navarro D, Goncalves C, Ferreira AC, Jorge C, Gil C, Aires I, Matias P, Mendes M, Azevedo A, Gomes F, Ferreira A, Perazzini C, Scutiero L, Brighenti L, Surace A, Steckiph D, Rovatti P, Severi S, Soltysiak J, Warzywoda A, Musielak A, Ostalska-Nowicka D, Zachwieja J, Goeksel T, Garnier H, Ritzerfeld M, Mann H, Babinet F, Allard B, Todorova V, Hamont C, Begri R, Dekker M, Taks M, Konings C, Scharnhorst V, Borawski J, Gozdzikiewicz-Lapinska J, Naumnik B, Lodi CA, Surace A, Grandi E, Rovatti P, Mancini E, Santoro A, Sereni L, Caiazzo M, Corazza L, Atti M, Palladino G, Sakurai K, Saito T, Hosoya H, Yamauchi F, Kurihara T, Tanibayashi Y, Ikebe N, Antonic M, Gubensek J, Drozg A, Vannier E, Mattio E, Todorova V, Ragon A, Brunet P, Klimm W, Pleskacz K, Pietrzak B, Niemczyk S, Leypoldt JK, Bernardo A, Muller M, Marbury TC, Culleton BF, Zeraati AA, Hekmat R, Reyhani HR, Sharifipoor F, Bolasco P, Sitzia I, Monni A, Mereu MC, Pinna AM, Logias F, Ghisu T, Passaghe M, Gazzanelli L, Ganadu M, Piras A, Cossu M, Contu B, Palleschi S, Rossi B, Atti M, Caiazzo M, Sereni L, Palladino G, Ghezzi PM, Kron S, Schneditz D, Leimbach T, Aign S, Kron J, Seker Kockara A, Kayatas M, Huzmeli C, Candan F, Yilmaz MB, Ahmed BA, Bejosano CN, Samra Abouchacra SA, Al Falahi SZ, Abdul Moniem KM, Dastoor H, Kim S, Oh J, Sin Y, Kim J, Lee J. HAEMODIALYSIS TECHNIQUES AND ADEQUACY 2. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu173] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
31
|
Torrinha A, Gomes F, Oliveira M, Cruz R, Mendes E, Delerue-Matos C, Casal S, Morais S. Commercial squids: Characterization, assessment of potential health benefits/risks and discrimination based on mineral, lipid and vitamin E concentrations. Food Chem Toxicol 2014; 67:44-56. [DOI: 10.1016/j.fct.2014.02.014] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2013] [Revised: 01/21/2014] [Accepted: 02/11/2014] [Indexed: 12/11/2022]
|
32
|
Verstraeten R, Caraher M, Raats K, Penalvo JL, Gomes F, Miller R, Matthys C. Creative thinking as an innovative approach to tackle nutrition in times of economic crises. NUTR BULL 2014. [DOI: 10.1111/nbu.12078] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- R. Verstraeten
- Nutrition & Child Health Unit; Institute of Tropical Medicine; Antwerp Belgium
| | - M. Caraher
- Centre for Food Policy; London City University; London UK
| | - K. Raats
- Creative thinking facilitator; Schoten Belgium
| | - J. L. Penalvo
- Epidemiology and Population Genetics; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Madrid Spain
| | - F. Gomes
- Diabetes and Nutritional Sciences Division; School of Medicine; King's College London; London UK
| | - R. Miller
- British Nutrition Foundation; London UK
| | - C. Matthys
- Department of Clinical and Experimental Medicine; Clinical and Experimental Endocrinology; Leuven Belgium
| | | |
Collapse
|
33
|
Gomes F, Teixeira P, Oliveira R. Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies. Biofouling 2014; 30:131-141. [PMID: 24283376 DOI: 10.1080/08927014.2013.848858] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Staphylococcus epidermidis is nowadays regarded as the most frequent cause of nosocomial infections and indwelling medical device-associated infections. One of the features that contributes to the success of this microorganism and which is elemental to the onset of pathogenesis is its ability to form biofilms. Cells in this mode of growth are inherently more resistant to antimicrobials. Seeking to treat staphylococcal-related infections and to prevent their side effects, such as the significant morbidity and health care costs, many efforts are being made to develop of new and effective antistaphylococcal drugs. Indeed, due to its frequency and extreme resistance to treatment, staphylococcal-associated infections represent a serious burden for the public health system. This review will provide an overview of some conventional and emerging anti-biofilm approaches in the management of medical device-associated infections related to this important nosocomial pathogen.
Collapse
Affiliation(s)
- F Gomes
- a Centre of Biological Engineering, IBB - Institute for Biotechnology and Bioengineering, University of Minho , Braga , Portugal
| | | | | |
Collapse
|
34
|
Gomes F, Gonçalves D, Gonçalves M, Nascimento M, Novo R, Soares C. EPA-1732 – Gender transition: biological and psychosocial features of adjusting to sex reassignment - crossing literature with psychometric data from a clinical sexology unit in lisbon. Eur Psychiatry 2014. [DOI: 10.1016/s0924-9338(14)78866-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
35
|
Nascimento M, Azevedo M, Gomes F, Bacelar F, Ramos A, Nobre A. EPA-1729 – Pychoeducation in bipolar patients: does it help preventing hospitalization? a review of the program done in a portuguese psychiatric hospital. Eur Psychiatry 2014. [DOI: 10.1016/s0924-9338(14)78864-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
36
|
Gomes F, Hookway C, Weekes CE. Royal College of Physicians Intercollegiate Stroke Working Party evidence-based guidelines for the nutritional support of patients who have had a stroke. J Hum Nutr Diet 2013; 27:107-21. [PMID: 24252162 DOI: 10.1111/jhn.12185] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
BACKGROUND Stroke affects 15 million people each year worldwide and is one of the world's leading causes of death and physical disability. Stroke can result in a decline in nutritional status and this is associated with increased mortality and poor outcomes. The present work aimed to systematically review key aspects of the nutritional support of stroke patients at risk of malnutrition and to provide evidence-based guidelines for use in clinical practice. The work was conducted as part of the process to develop the 4th edition of the Royal College of Physicians' (RCP) 'National Clinical Guideline (NCG) for Stroke'. METHODS Questions were generated by the search team, together with contributions from members of the Virtual Stroke Group and the RCP Intercollegiate Stroke Working Party Guideline Development Group. Six questions covering several areas of nutritional support after stroke were defined and searches were conducted through to 31 October 2011 using five electronic databases (Embase, Medline, CINAHL, Cochrane Library and Web of Science). All included studies were assessed for quality and risk of bias using the van Tulder criteria for randomised controlled trials (RCTs) and the Quorum criteria for systematic reviews. RESULTS In total, 4215 abstracts were identified, 24 papers were reviewed and 13 systematic reviews and RCTs were included to provide evidence for the nutritional support components of the guidelines. For each question, evidence statements, recommendations and practical considerations were developed. CONCLUSIONS This systematic review process has resulted in the development of evidence-based guidelines for use in clinical practice and has identified areas for further research.
Collapse
Affiliation(s)
- F Gomes
- Diabetes and Nutritional Sciences Division, School of Medicine, King's College London, London, UK
| | | | | | | |
Collapse
|
37
|
Aguiar J, Schneider H, Gomes F, Carneiro J, Santos S, Rodrigues LR, Sampaio I. Genetic variation in native and farmed populations of Tambaqui (Colossoma macropomum) in the Brazilian Amazon: regional discrepancies in farming systems. AN ACAD BRAS CIENC 2013; 85:1439-47. [PMID: 24141412 DOI: 10.1590/0001-376520130007] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2013] [Accepted: 04/12/2013] [Indexed: 11/21/2022] Open
Abstract
The tambaqui, Colossoma macropomum, is the most popular fish species used for aquaculture in Brazil but there is no study comparing genetic variation among native and farmed populations of this species. In the present study, we analyzed DNA sequences of the mitochondrial DNA to evaluate the genetic diversity among two wild populations, a fry-producing breeding stock, and a sample of fish farm stocks, all from the region of Santarém, in the west of the Brazilian state of Pará. Similar levels of genetic diversity were found in all the samples and surprisingly the breeding stock showed expressive representation of the genetic diversity registered on wild populations. These results contrast considerably with those of the previous study of farmed stocks in the states of Amapá, Pará, Piauí, and Rondônia, which recorded only two haplotypes, indicating a long history of endogamy in the breeding stocks used to produce fry. The results of the two studies show two distinct scenarios of tambaqui farming in the Amazon basin, which must be better evaluated in order to guarantee the successful expansion of this activity in the region, and the rest of Brazil, given that the tambaqui and its hybrids are now farmed throughout the country.
Collapse
Affiliation(s)
- Jonas Aguiar
- Laboratório de Genética e Biodiversidade/LGBIO, Universidade Federal do Oeste do Pará/UFOPA, 68040-440SantarémPA, Brasil
| | - Horacio Schneider
- Laboratório de Genética e Biologia Molecular, Instituto de Estudos Costeiros, Universidade Federal do Pará/UFPA, 68600-000BragançaPA, Brasil
| | - Fátima Gomes
- Laboratório de Genética e Biologia Molecular, Instituto de Estudos Costeiros, Universidade Federal do Pará/UFPA, 68600-000BragançaPA, Brasil
| | - Jeferson Carneiro
- Laboratório de Genética e Biologia Molecular, Instituto de Estudos Costeiros, Universidade Federal do Pará/UFPA, 68600-000BragançaPA, Brasil
| | | | - Luis R Rodrigues
- Laboratório de Genética e Biologia Molecular, Instituto de Estudos Costeiros, Universidade Federal do Pará/UFPA, 68600-000BragançaPA, Brasil
| | | |
Collapse
|
38
|
Oliveira A, Pinto C, Silva C, Gomes F, Pinto G, Sousa M, Santos M. Brazilian Comfort Foods: A Nutritional Strategy for Cancer Patients Receiving Palliative Care. J Acad Nutr Diet 2013. [DOI: 10.1016/j.jand.2013.06.093] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
39
|
Barata P, Oliveira S, Mascarenhas L, Gomes F, Ribeiro C, Custódio M, Costa L, Araújo A, Batarda L. Breast Cancer in Women: Too Young or Too Old? Ann Oncol 2013. [DOI: 10.1093/annonc/mdt089.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
40
|
Encarnação R, Moura M, Gomes F, Da Silva PC. Caracterização dos casos observados numa equipa de psiquiatria da infância e adolescência. Um estudo retrospectivo. ACTA MEDICA PORT 2012. [DOI: 10.20344/amp.1423] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Child Mental Health Services have been dealing¸ over the last decades, with a growing number of children in need of evaluation and treatment. Recent studies estimate that 10 to 20% of children and adolescents met criteria for, at least, one psychiatric diagnosis, and that only one fifth gets appropriate treatment. Thus, in order to optimize service planning and management we performed an analysis of the cases referred to and observed at one Child and Adolescent Psychiatry Clinic between 2004 and 2007, as well as descriptive analysis of the youth population observed at the same clinic during 2007. In the 4 year period studied, 1923 children were consulted in a total of 9609 appointments. Sample mean age was 9.89 years with a clear male gender preponderance. During 2007, 480 patients were consulted and it was possible to observe a predominance of nuclear family structure and around 71% of cases living in Sintra. Regarding the source of referral, 29% of the cases were referred by the assistant physician and in 26% by school teachers; the main complaints were behavior problems (30%) and learning disabilities (15%). It was also possible to characterize complaints according to the different referral sources. On a psychodynamic diagnostic level, 56% of all cases met criteria for a Depressive Organization. According to DSM-IV-TR diagnostic criteria for Axis I disorders, we found 30% of Emotional Disorders and 24.8% of Conduct Disorders and Attention Deficit and Hyperactive Disorder. Mean waiting times between referral and the first appointment varied between 55 days (cases referred from the Emergency Department) and 141 days (school referrals). Only a deeper and detailed analysis of this reality will allow the planning and implementation of measures needed to optimize Child and Adolescent Mental Health services and the answer they can give to patients and families.
Collapse
|
41
|
Gomes F, Schneider H, Barros C, Sampaio D, Hashimoto D, Porto-Foresti F, Sampaio I. Innovative molecular approach to the identification of Colossoma macropomum and its hybrids. AN ACAD BRAS CIENC 2012; 84:517-26. [PMID: 22534749 DOI: 10.1590/s0001-37652012005000025] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2011] [Accepted: 11/09/2011] [Indexed: 11/21/2022] Open
Abstract
Tambaqui (Colossoma macropomum) is the fish species most commonly raised in the Brazilian fish farms. The species is highly adaptable to captive conditions, and is both fast-growing and relatively fecund. In recent years, artificial breeding has produced hybrids with Characiform species, known as "Tambacu" and "Tambatinga". Identifying hybrids is a difficult process, given their morphological similarities with the parent species. This study presents an innovative molecular approach to the identification of hybrids based primarily on Multiplex PCR of a nuclear gene (α-Tropomyosin), which was tested on 93 specimens obtained from fish farms in northern Brazil. The sequencing of a 505-bp fragment of the Control Region (CR) permitted the identification of the maternal lineage of the specimen, all of which corresponded to C. macropomum. Unexpectedly, only two CR haplotype were found in 93 samples, a very low genetic diversity for the pisciculture of Tambaqui. Multiplex PCR identified 42 hybrids, in contrast with 23 identified by the supplier on the basis of external morphology. This innovative tool has considerable potential for the development of the Brazilian aquaculture, given the possibility of the systematic identification of the genetic traits of both fry-producing stocks, and the fry and juveniles raised in farms.
Collapse
Affiliation(s)
- Fátima Gomes
- Instituto de Estudos Costeiros, Laboratório de Genética e Biologia Molecular, Universidade Federal do Pará, Bragança, PA, Brasil
| | | | | | | | | | | | | |
Collapse
|
42
|
Encarnação R, Moura M, Gomes F, da Silva PC. [Characterization of the cases referred and consulted in a child and adolescent psyschiatry clinic. A retrospective study]. ACTA MEDICA PORT 2011; 24:925-934. [PMID: 22713187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2010] [Accepted: 11/25/2010] [Indexed: 06/01/2023]
Abstract
Child Mental Health Services have been dealing¸ over the last decades, with a growing number of children in need of evaluation and treatment. Recent studies estimate that 10 to 20% of children and adolescents met criteria for, at least, one psychiatric diagnosis, and that only one fifth gets appropriate treatment. Thus, in order to optimize service planning and management we performed an analysis of the cases referred to and observed at one Child and Adolescent Psychiatry Clinic between 2004 and 2007, as well as descriptive analysis of the youth population observed at the same clinic during 2007. In the 4 year period studied, 1923 children were consulted in a total of 9609 appointments. Sample mean age was 9.89 years with a clear male gender preponderance. During 2007, 480 patients were consulted and it was possible to observe a predominance of nuclear family structure and around 71% of cases living in Sintra. Regarding the source of referral, 29% of the cases were referred by the assistant physician and in 26% by school teachers; the main complaints were behavior problems (30%) and learning disabilities (15%). It was also possible to characterize complaints according to the different referral sources. On a psychodynamic diagnostic level, 56% of all cases met criteria for a Depressive Organization. According to DSM-IV-TR diagnostic criteria for Axis I disorders, we found 30% of Emotional Disorders and 24.8% of Conduct Disorders and Attention Deficit and Hyperactive Disorder. Mean waiting times between referral and the first appointment varied between 55 days (cases referred from the Emergency Department) and 141 days (school referrals). Only a deeper and detailed analysis of this reality will allow the planning and implementation of measures needed to optimize Child and Adolescent Mental Health services and the answer they can give to patients and families.
Collapse
Affiliation(s)
- Ricardo Encarnação
- Área de Pedopsiquiatria, Hospital Dona Estefânia (CHLC), Lisbon, Portugal
| | | | | | | |
Collapse
|
43
|
Cardoso RMS, Filipe HAL, Gomes F, Moreira ND, Vaz WLC, Moreno MJ. Chain length effect on the binding of amphiphiles to serum albumin and to POPC bilayers. J Phys Chem B 2010; 114:16337-46. [PMID: 21090614 DOI: 10.1021/jp105163k] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The interaction of small molecules, such as drugs or metabolites, with proteins and biomembranes is of fundamental importance for their bioavailability. The systematic characterization of the binding affinity for structurally related ligands may provide rules that allow its prediction for any other relevant molecule. In this work we have studied a homologous series of fluorescent fatty amines with the fluorescent moiety 7-nitrobenz-2-oxa-1,3-diazol-4-yl covalently bound to the amine group (NBD-C(n); n = 4, 6, 8, 10, 12, 14, and 16) in aqueous solution and associated with BSA or lipid bilayers. We have found a linear dependence with the length of the alkyl chain, up to NBD-C(10), for the Gibb's free energy of partition between the aqueous solution and 1-palmitoyl-2-oleoyl phosphatidylcholine bilayers equal to ΔΔG = -2.5 ± 0.3 kJ/mol per methylene group. Additionally, the amphiphiles interacted efficiently with bovine serum albumin, and it was inhibited by fatty acids indicating that binding occurs to the fatty acids highest affinity binding site. The association of the amphiphiles with BSA and POPC bilayers was performed at different temperatures (15-35 °C) allowing for the calculation of the enthalpic and entropic contributions. A value of ΔH = -15 ± 4 kJ/mol was obtained for all amphiphiles and binding agents. The entropy contribution was always positive and increased with the length of the alkyl chain. The location of the ligand in the biological membrane is also of high relevance, namely because this will determine its effect on biomembrane properties at high ligand concentrations. With this goal, we have measured some photophysical properties of the amphiphiles inserted in POPC bilayers, and we found no significant variation along the series, indicating that the NBD group is located in a region with similar properties regardless of the length of the nonpolar group. An exception was noted for the case of NBD-C(14) whose parameters were somewhat different from the trend observed.
Collapse
Affiliation(s)
- R M S Cardoso
- Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade de Coimbra, Largo D. Dinis, Rua Larga, 3004-535 Coimbra, Portugal
| | | | | | | | | | | |
Collapse
|
44
|
Campos FS, Dezen D, Antunes DA, Santos HF, Arantes TS, Cenci A, Gomes F, Lima FES, Brito WMED, Filho HCK, Batista HBCR, Spilki FR, Franco AC, Rijsewijk FAM, Roehe PM. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine. Vet Microbiol 2010; 148:18-26. [PMID: 20828945 DOI: 10.1016/j.vetmic.2010.08.004] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2010] [Revised: 07/25/2010] [Accepted: 08/06/2010] [Indexed: 11/18/2022]
Abstract
Bovine herpesvirus type 5 (BoHV-5) is the causative agent of bovine herpetic encephalitis. In countries where BoHV-5 is prevalent, attempts to vaccinate cattle to prevent clinical signs from BoHV-5-induced disease have relied essentially on vaccination with BoHV-1 vaccines. However, such practice has been shown not to confer full protection to BoHV-5 challenge. In the present study, an inactivated, oil adjuvanted vaccine prepared with a recombinant BoHV-5 from which the genes coding for glycoprotein I (gI), glycoprotein E (gE) and membrane protein US9 were deleted (BoHV-5 gI/gE/US9(-)), was evaluated in cattle in a vaccination/challenge experiment. The vaccine was prepared from a virus suspension containing a pre-inactivation antigenic mass equivalent to 10(7.69) TCID(50)/dose. Three mL of the inactivated vaccine were administered subcutaneously to eight calves serologically negative for BoHV-5 (vaccinated group). Four other calves were mock-vaccinated with an equivalent preparation without viral antigens (control group). Both groups were boostered 28 days later. Neither clinical signs of disease nor adverse effects were observed during or after vaccination. A specific serological response, revealed by the development of neutralizing antibodies, was detected in all vaccinated animals after the first dose of vaccine, whereas control animals remained seronegative. Calves were subsequently challenged on day 77 post-vaccination (pv) with 10(9.25) TCID(50) of the wild-type BoHV-5 (parental strain EVI 88/95). After challenge, vaccinated cattle displayed mild signs of respiratory disease, whereas the control group developed respiratory disease and severe encephalitis, which led to culling of 2/4 calves. Searches for viral DNA in the central nervous system (CNS) of vaccinated calves indicated that wild-type BoHV-5 did not replicate, whereas in CNS tissues of calves on the control group, viral DNA was widely distributed. BoHV-5 shedding in nasal secretions was significantly lower in vaccinated calves than in the control group on days 2, 3, 4 and 6 post-challenge (pc). In addition, the duration of virus shedding was significantly shorter in the vaccinated (7 days) than in controls (12 days). Attempts to reactivate latent infection by administration of dexamethasone at 147 days pv led to recrudescence of mild signs of respiratory disease in both vaccinated and control groups. Infectious virus shedding in nasal secretions was detected at reactivation and was significantly lower in vaccinated cattle than in controls on days 11-13 post-reactivation (pr). It is concluded that the inactivated vaccine prepared with the BoHV-5 gI/gE/US9(-) recombinant was capable of conferring protection to encephalitis when vaccinated cattle were challenged with a large infectious dose of the parental wild type BoHV-5. However, it did not avoid the establishment of latency nor impeded dexamethasone-induced reactivation of the virus, despite a significant reduction in virus shedding after challenge and at reactivation on vaccinated calves.
Collapse
Affiliation(s)
- F S Campos
- Virology Laboratory, Microbiology Department, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul (UFRGS), Av. Sarmento Leite 500, Porto Alegre, CEP 90050-170, Rio Grande do Sul (RS), Brazil.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Versieren K, Heindryckx B, Qian C, Gerris J, De Sutter P, Exposito Navarro A, Ametzazurra A, Nagore D, Crisol L, Aspichueta F, Mendoza R, Matorras R, Garcia MM, Valley JK, Swinton PS, Boscardin WJ, Lue TF, P. Rinaudo, Wu MC, Bern O, Strassburger D, Komarovsky D, Kasterstein E, Komsky A, Maslansky B, Raziel A, Friedler S, Gidoni Y, Ron-El R, Tang J, Fang C, Zhang MF, Li T, Zhuang GL, Suh DS, Joo JK, Choi JR, Kim SC, JO MS, Kim KH, Lee KS, Katz-Jaffe MG, Stevens J, McCormick S, Smith R, Schoolcraft WB, Ben-Ami I, Komsky A, Strassburger D, Bern O, Komarovsky D, Kasterstein E, Maslansky B, Raziel A, Friedler S, Gidoni Y, Ron-El R, Koch J, Costello M, Kilani S, Namm A, Arend A, Aunapuu M, Joo JK, Lee KS, Choi YM, Cho JD, Sipe C, Pelts EJ, Matthews JM, Sanchez SR, Brohammer RLB, Wagner Y, Liebermann J, Uhler M, Beltsos A, Chen MJ, Guu HF, Chen YF, Yih YJ, Ho JYP, Lin TY, Ho ESC, Lopes FB, Figueira RCS, Braga DPAF, Ferreira RC, Aoki T, Iaconelli A, Borges E, Van de Velde H, Cauffman G, Verloes A, De Paepe C, Sterckx J, Van Ranst H, Devroey P, Tournaye H, Liebaers I, Santos MA, Teklenburg G, Macklon NS, Van Opstal D, Schuring-Blom GH, Krijtenburg PJ, de Vreeden-Elbertse J, Fauser BC, Baart EB, Cawood S, Doshi A, Gotts S, Serhal P, Milachich T, Petkova L, Barov D, Shterev A, Esteves TC, Balbach ST, Arauzo-Bravo MJ, Pfeiffer MJ, Boiani M, Le Gac S, van Rossem F, Esteves T, Bioani M, van den Berg A, Valeri C, Pappalardo S, De Felici M, Manna C, Ryu H, Park CY, Min SH, Choi SK, Park C, Lee SH, Kim KR, Jeong H, Chi HJ, Wittemer C, Celebi C, Viville S, Luceno Maestre F, Castilla Alcala JA, Gomez-Palomares JL, Cabello Y, Hernandez J, Marqueta J, Herrero J, Vidal E, Fernandez-Shaw S, Coroleu B, McRae C, Baskind E, Sharma V, Fisher J, Boldi Cotti P, Colasante C, Perego L, De Lauretis L, Montag M, Koster M, Nikolov A, van der Ven H, Lee SG, Lee YC, Kang SM, Kang YJ, Shin YK, Jung JH, Lim JH, Dorfmann A, Carroll K, Sisson M, Geltinger M, Yap S, Iwaszko M, Hara T, Naruse K, Matsuura K, Kodama T, Sato K, Tateaki Y, Tanaka J, Minasi MG, Scarselli F, Rubino P, Casciani V, Colasante A, Lobascio M, Alviggi E, Ferrero S, Litwicka K, Iammarrone E, Cucinelli F, Giannini PG, Tocci A, Nagy ZP, Greco E, Borini A, Tarozzi N, Fiorentin D, Bonu MA, Nadalini M, Johnson J, De Santis L, Bianchi V, Casciani V, Rubino P, Minasi MG, Colasante A, Scarselli F, Lobascio AM, Arizzi L, Iammarrone E, Litwicka K, Ferrero S, Tocci A, Piscitelli C, Cucinelli F, Nagy ZP, Greco E, Mesut N, Ciray HN, Mesut A, Aksoy T, Bahceci M, Lee YM, Chen HW, Wu P, Tzeng CR, Antonova I, Milachich T, Petkova L, Yunakova M, Chaveeva P, A. Shterev, Hlinka D, Dudas M, Rutarova J, Rezacova J, Lazarovska S, Aoi Y, Takahashi H, Saitou H, Takiue C, Kawakami N, Tone M, Hirata R, Terada S, Yoshioka N, Habara T, Hayashi N, Montagut J, Bonald F, Guillen N, Guitard V, Balu-Genvrin E, Crae E, Nogueira D, Silva J, Cunha M, Viana P, Teixeira da Silva JM, Oliveira C, Goncalves A, Barros N, Sousa M, Barros A, van de Werken C, Jahr H, Laven JSE, Baart EB, Gamiz Izquierdo P, De los Santos JM, Tejera A, Pellicer A, Romero JL, Galan A, Albert C, Santos MJDL, Adriaenssens T, Wathlet S, Segers I, Verheyen G, Van De Velde H, Coucke W, Devroey P, Smitz J, Paternot G, D'Hooghe TM, Debrock S, Spiessens C, Hwang HK, Kim HM, Lee JH, Jung YJ, Kang A, Kook MJ, Jung JY, An SJ, Kwon HC, Lee SJ, Somova O, Feskov A, Feskova I, Chumakova N, Zozulina O, Zhilkova YE, Binda M, Campo R, Van Kerkhoven G, Frederickx V, Serneels A, Roziers P, Vranken I, Lopes AS, Van Nuland A, Gordts S, Puttemans P, Valkenburg M, Gordts S, Rodriguez-Arnedo A, Ten J, Guerrero J, Lledo B, Carracedo MA, Ortiz JA, Llacer J, Bernabeu R, Usui K, Nakajo Y, Ota M, Hattori H, Kyoya T, Takisawa T, Kyono K, Ferrieres A, Poulain M, Loup V, Anahory T, Dechaud H, Hamamah S, Eckert J, Premkumar G, Lock F, Brooks S, Haque S, Cameron IT, Cheong Y, Fleming TP, Prados N, Ruiz M, Garcia-Ortega J, Vime P, Hernaez MJ, Crespo M, Fernandez-Sanchez M, Pellicer A, Hashimoto S, Kato N, Saeki K, Morimoto Y, Leung CON, Pang RTK, Liu WM, Lee KF, Yeung WSB, Wada T, Elliott T, Kahn J, Lowderman J, Wright G, Chang C, Bernal D, Kort H, Nagy Z, de los Santos JM, Escrich L, Grau N, Pellicer A, Romero JL, Escriba MJ, Escriba M, Grau N, Escrich L, de los Santos JM, Pellicer A, Romero JL, Tasker F, Hamoda H, Wilner H, Grace J, Khalaf Y, Miyaji S, Mizuno S, Horiuchi L, Haruki A, Fukuda A, Morimoto Y, Utsunomiya T, Kumasako Y, Ito H, Goto K, Koike M, Abe H, Sakamoto T, Kojima F, Koshika T, Muzii L, Magli MC, Gioia L, Scaravelli G, Ferraretti AP, Gianaroli L, Capoti A, Magli MC, Lappi M, Maggi E, Ferraretti AP, Gianaroli L, Scott L, Finn A, Kloos B, Davies D, Yamada M, Hamatani T, Akutsu H, Chikazawa N, Ogawa S, Okumura N, Mochimaru Y, Kuji N, Aoki D, Yoshimura Y, Umezawa A, Aprysko VP, Yakovenko SA, Seregina EA, Yutkin EV, Yelke H, Milik S, Candan ZN, Altin G, Unal S, Atayurt Z, Y. Kumtepe, Chung JT, Son WY, Zhang X, Tan SL, Ao A, Seli E, Botros L, Henson M, Roos P, Judge K, Sakkas D, group MSGMS, Feliciano M, Monahan D, Ermolovich E, Rosenwaks Z, Palermo GD, Mantikou E, van Echten-Arends J, Sikkema-Raddatz B, van der Veen F, Repping S, Mastenbroek S, Botros L, Seli E, Henson M, Roos P, Judge K, Sakkas D, Group MBS, Wells V, Thum MY, Abdalla HI, Machiya R, Akimoto S, Nobuyoshi T, Yoshii N, Hosaka T, Odawara Y, Heindryckx B, Vanden Meerschaut F, Lierman S, Qian C, O'Leary T, Gerris J, De Sutter P, Assou S, Haouzi D, Pellestor F, Monzo C, Dechaud H, De Vos J, Hamamah S, Conaghan J, Fischer E, Popwell J, Ryan I, Chenette P, Givens C, Schriock E, Herbert C, Ermolovich E, Monahan D, Neri QV, Rosenwaks Z, Palermo GD, Verheyen G, Camus M, Van de Velde H, Haentjens P, Devroey P, Mugica A, Esbert M, Molina JM, Garrido N, Pellicer A, Ballesteros A, Calderon G, Rossi ALS, Rocha AM, Alegretti JR, Hassun PA, Gomes LP, Criscuollo T, Serafini P, Motta ELA, Munoz M, Meseguer M, Cruz M, Perez-Cano I, Pellicer A, Gadea B, Martinez M, Fortuno S, Gundersen J, Garrido N, Cruz M, Garrido N, Perez-Cano I, Munoz M, Pellicer A, Martinez M, Gadea B, Selles E, Betersen J, Meseguer M, Le Meaux E, Assou S, Haouzi D, Loup V, Dechaud H, De Vos J, Hamamah S, Ouandaogo G, Assou S, Haouzi D, Ferrieres A, Anahory T, De Vos J, Hamamah S, Monzo C, Assou S, Haouzi D, Pellestor F, Dechaud H, De Vos J, S. Hamamah, Gismano E, Borini A, Cino I, Calzi F, Rabellotti E, Papaleo E, Bianchi V, De Santis L, Sunkara SK, Siozos A, Bolton V, Khalaf Y, Braude P, El-Toukhy T, Cho YS, Ambruosi B, Totaro P, Dell'Aquila ME, Gioacchini G, Bizzaro D, Giorgini E, Ferraris P, Sabbatini S, Carnevali O, Knaggs P, Chau A, Khalil S, Trew G, Lavery S, Jovanovic VP, Gomez R, Sauer CM, Shawber CJ, Outtz HH, Wang X, Sauer MV, Kitajewski J, Zimmermann RC, Mahrous E, Clarke H, Virant-Klun I, Bacer-Kermavner L, Mivsek J, Tomazevic T, Pozlep B, Zorn B, Vrtacnik-Bokal E, Dundure I, Bazarova J, Fodina V, Brikune J, Lakutins J, Jee B, Jo J, Lee J, Suh C, Kim S, Moon S, Shufaro Y, Lebovich M, Aizenman E, Simon A, Laufer N, A. Saada Reisch, Ribeiro MA, Pinto A, Gomes F, Silva Carvalho JL, Almeida H, Massaro FC, Petersen CG, Mauri AL, Silva LFI, Nicoletti APM, Cavagna M, Pontes A, Baruffi RLR, Oliveira JBA, Franco JG, Valcarcel A, Viglierchio MI, Tiveron M, Guidobono M, Inza R, Vilela M, Vilela M, Valcarcel A, Viglierchio MI, Kenny A, Lombardi C, Marconi G. Posters * Embryology (Embryo Selection). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.140] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
46
|
Maldonado L, Azjen SA, Aoki T, Busato W, Pasqualotto FF, Iaconelli A, Borges E, Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L, Kolibianakis EM, Venetis CA, Diedrich K, Tarlatzis BC, Griesinger G, Lehert P, Ezcurra D, Guzeloglu Kayisli O, Lalioti M, Sasson I, Sakkas D, Aydiner F, Seli E, Almeida H, Ribeiro A, Pinto A, Gomes F, Silva-Carvalho JL, Porrati L, Vilela M, Viglierchio MI, Valcarcel A, Lombardi E, Marconi G. Session 64: Clinical Art 2. Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.64] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
47
|
Gomes F, Simões M, Diaz A, Requena G, Lopes M, Canhoto J. Effect of PGRs and genotype on the multiplication of micropropagated cultures of Arbutus unedo L. (Strawberry Tree) adult selected trees. N Biotechnol 2009. [DOI: 10.1016/j.nbt.2009.06.890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
48
|
Canhoto J, Lopes M, Gomes F. Propagation of Arbutus unedo L. (strawberry tree) through somatic embryogenesis: maturation and conversion of somatic embryos. N Biotechnol 2009. [DOI: 10.1016/j.nbt.2009.06.897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
49
|
Matos L, Stevenson D, Gomes F, Silva-Carvalho J, Almeida H. Superoxide dismutase expression in human cumulus oophorus cells. Mol Hum Reprod 2009; 15:411-9. [DOI: 10.1093/molehr/gap034] [Citation(s) in RCA: 78] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
50
|
Murugappan K, Gomes F, Waxman B. GS03�**ABDOMINAL WOUND DEHISCENCE - WHO IS REALLY AT RISK? ANZ J Surg 2009. [DOI: 10.1111/j.1445-2197.2009.04917_3.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|